NEW YORK, June 21, 2021 /PRNewswire/ -- The electroporation instruments market is expected to grow by USD 87.59 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the electroporation instruments market in optimistic, probable, and pessimistic forecast scenarios.
The electroporation instruments market will witness a positive impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
With the continuing spread of the coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
Key Considerations for Market Forecast:
Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
Pre- as well as post-COVID-19 market estimates
Quarterly impact analysis and updates on market estimates
The electroporation instruments market is driven by the rising demand for monoclonal antibodies. In addition, the growing incidence and prevalence of cancer is expected to trigger the electroporation instruments market toward witnessing a CAGR of almost 8% during the forecast period.
Major Five Electroporation Instruments Market Participants: BEX Co. Ltd.: The company offers electroporation instruments such as CUY21EDI.
Bio Rad Laboratories, Inc: The company offers electroporation instruments such as Gene Pulser Xcell Electroporation Systems.
Celetrix LLC: The company offers electroporation instruments such as the Celestrix electroporation series.
Eppendorf AG: The company offers electroporation instruments such as Eporator.
Harvard Bioscience Inc.: The company offers electroporation instruments such as BTX Molecular Delivery Systems.
Electroporation Instruments Market 2021-2025: Segmentation Electroporation instruments market is segmented as below:
Pharma And Biotech Companies
Academic And Research Institutes
Related Report on Healthcare Include: Global Medical Devices Market - Global medical devices market report identifies the increasing prevalence of diseases as one of the major drivers. Know about other interesting factors and statistics related to the medical devices market. View Statistics Data Here
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.